Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol versus pregabalin for central sensitization in chronic pain
NL-OMON20680Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tapentadol and pregabalin in chronic pain, endometriosis and chronic low back pain (CLBP) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Pressure pain threshold, Pressure pain tolerance threshold and 4 more. Started Jan 2019; status: recruiting.
02
Drugs
tapentadolpregabalin
03
Conditions
chronic painendometriosischronic low back pain (CLBP)
Beyond the preview
Go deeper on NL-OMON20680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20680.